Assembly Biosciences Inc (NASDAQ: ASMB) stock suffered a major decline of -11.0% on 4/17/24. The shares closed at $12.92. Trading volume in this decline was normal. The stock has been strong relative to the market over the last nine months but has declined -13.0% during the last week.
Current PriceTarget Research Rating
ASMB is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
Assembly Biosciences has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Assembly Biosciences has a neutral Power Rating of 46 but a very low Appreciation Score of 5, producing the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment